An explosion in Medicare spending on epilepsy testing resembles a pattern of improper payments for genetic testing that was ...

The firm is leading a collaborative project on the development of a test to detect markers of 36 types of cancer in breath and urine samples.

The company recently reported that the four-protein test with algorithm-based analysis performed with 83.5 percent sensitivity and 90.3 percent specificity.

NEW YORK – Hemex Health and Terumo Blood and Cell Technologies have partnered to expand access to rapid and affordable Hb variant testing to detect sickle cell disease. The firms will collaborate on ...

The BrightKaire test converts stem cells to neurons and exposes those neurons to different antidepressants to determine how ...

The investment bank expects Hologic to grow in the mid-single digits with recovery in its Breast Health business and an uptick in its Gyn Surgical business.

The new controls, called Specialty Immunoassay Plus, incorporate clinically relevant analytes in a liquid format.

Last week, readers were most interested in a story about gastrointestinal bacterial pathogen panels from Hologic getting regulatory authorizations.

The tool assesses progressive decline in kidney function and will be launched as part of Roche's new chronic kidney disease algorithm panel.